Similar documents
Evaluation of contrast-enhanced ultrasound for diagnosis of dysplastic nodules with a focus of hepatocellular carcinoma in liver cirrhosis patients

RICCARDO LENCIONI,CLOTILDE DELLA PINA, LAURA CROCETTI,DANIA CIONI. Chapter 1

Mædica - a Journal of Clinical Medicine

INTRODUCTION. Key Words: Contrast enhanced ultrasonography; Liver masses. ORiginal Article

Focal Hypoechoic Tumors of Fatty Liver

The UGent Institutional Repository is the electronic archiving and dissemination platform for

Contrast Enhanced Ultrasound of Parenchymal Masses in Children

Detection and Characterization of Hepatocellular Carcinoma by Imaging

Ultrasound contrast agents (USCA)

LIVER IMAGING TIPS IN VARIOUS MODALITIES. M.Vlychou, MD, PhD Assoc. Professor of Radiology University of Thessaly

Modern liver imaging techniques - A new era in liver ultrasound

Innovations in HCC Imaging: MDCT/MRI

Byung Ihn Choi, M.D. Department of Radiology Seoul National University Hospital

HCC and mass effect. Hepatocellular cancer: what if the AFP is rising but no lesion seen on imaging? What you need to know about AFP.

dimeglumine enhanced MRI.

Evangelos Chartampilas Bioclinic Hospital Thessaloniki, Greece

Contrast-Enhanced Ultrasound in Assessing Therapeutic Response in Ablative Treatments of Hepatocellular Carcinoma

U ltrasonography (US) is reported to be the primary

Contrast-enhanced ultrasound for characterisation of hepatic lesions appearing non-hypervascular on CT in chronic liver diseases

Focal Hepatic Lesions: Contrast- Enhancement Patterns at Pulse-Inversion Harmonic US using a Microbubble Contrast Agent

S th US Contrast

Early detection and characterization of hepatocellular. Early Detection and Curative Treatment of Early-Stage Hepatocellular Carcinoma

Diagnostics guidance Published: 29 August 2012 nice.org.uk/guidance/dg5

The role of contrast enhanced ultrasound (ceus) in the assessment of liver nodules in patients with cirrhosis

Atypically large well-differentiated hepatocellular carcinoma with extensive fatty metamorphosis : ReportofaCase

Characterization of Focal Liver Lesions using Contrast Enhanced Ultrasound as a First Line Method: a Large Monocentric Experience

Liver Cancer And Tumours

Compute-aided Differentiation of Focal Liver Disease in MR Imaging

Contrast-enhanced ultrasound of solitary thyroid nodules - qualitative and quantitative evaluation: initial results

Surveillance for Hepatocellular Carcinoma

The Diagnosis of Hypovascular Hepatic Lesions Showing Hypo-intensity in the Hepatobiliary Phase of Gd-EOB- DTPA-enhanced MR Imaging in High-risk

The Contribution of Contrast Enhanced Ultrasound for the characterization of benign liver lesions in clinical practice a monocentric experience

Small Liver Nodule Detection With a High-Frequency Transducer in Patients With Chronic Liver Disease

The role for contrast-enhanced ultrasonography outside of focal liver lesions

Sulfur hexafluoride-filled microbubbles SonoVue 3-7microns diameter Blood pool agent

Effective Health Care Program

Imaging techniques to characterize spleen involvement in patients with Hodgkin lymphoma

Due to its relatively low cost, safety and

Alice Fung, MD Oregon Health and Science University

NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE. Report for Guidance Executive

8/3/2016. Consultant for / research support from: Astellas Bayer Bracco GE Healthcare Guerbet Medrad Siemens Healthcare. Single Energy.

Contrast-Enhanced Ultrasonograpic Findings in Pancreatic Tumors

HCC e CEUS. Prof. A. Giorgio. Direttore IX UOC di Malattie Infettive ad Indirizzo Ecointerventistico

Clinical evaluation of new diagnostic modalities of EUS for pancreatobiliary diseases

Intrahepatic Sarcomatoid Cholangiocarcinoma with Portal Vein Thrombosis: A Case Report 1

Objectives. HCC Incidence and Mortality. Disclosure Statement HCC. Imaging of Hepatocellular Carcinoma. Treatment of Hepatocellular Carcinoma

Newcastle HPB MDM updated radiology imaging protocol recommendations. Author Dr John Scott. Consultant Radiologist Freeman Hospital

Guidelines for the use of contrast-enhanced ultrasound in hepatocellular carcinoma

Hepatocellular Carcinoma HCC Updated November 2015 by: Dr. Mohammed Alghamdi (Medical Oncology Fellow, University of Calgary)

Usefulness of Contrast Enhanced Ultrasound Guidance in Percutaneous Biopsies of Liver Tumors

Surveillance for HCC Who, how Diagnosis of HCC Surveillance for HCC in Practice

Contrast Enhanced US

An Algorithm for the Diagnosis of Focal Liver Masses Using Microbubble Contrast-Enhanced Pulse-Inversion Sonography

Hepatocellular carcinoma (HCC) is a malignant liver neoplasm

Gastrointestinal Imaging Original Research

Shear Wave Elastography In Characterization Of Liver Tumours

STANDARDIZED MANAGEMENT RECOMMENDATIONS FOR ADRENAL NODULES: EVIDENCE-BASED CONSENSUS POWERSCRIBE MACROS FROM AN ACADEMIC/PRIVATE PRACTICE

Technological advancements improve the sensitivity of CEUS diagnostics

Imaging features of hepatic angiomyolipomas on real-time contrast-enhanced ultrasound

Wenxin Xu, Harvard Medical School Year III. Gillian Lieberman, MD

Liver imaging the revolution

Original Article Gastrointestinal Imaging

Case Report Contrast Enhanced Ultrasound of a Gallbladder Lesion in a Patient with a History of Renal Cell and Rectal Cancer

Discrimination between neoplastic and non-neoplastic lesions in cirrhotic liver using contrast-enhanced ultrasound

*, Meng-Xia Yuan, Kuan-sheng Ma, Xiao-Wu Li, Chun-Lin Tang, Xiao-Hang Zhang, De-Yu Guo, Xiao-Chu Yan. Abstract. Introduction

HEPATOCYTE SPECIFIC CONTRAST MEDIA: WHERE DO WE STAND?

HEPATO-BILIARY IMAGING

Zoltan Harkanyi M.D., Ph.D. Department of Radiology, Heim Pal Children s Hospital, Budapest, Hungary

Utility of Adding Primovist Magnetic Resonance Imaging to Analysis of Hepatocellular Carcinoma by Liver Dynamic Computed Tomography

The clinical sign of pleurisy is characterized by a

Hepatobiliary and Pancreatic Malignancies

Imaging Diagnosis. Diagnostic confirmation and assessment of

Inflammatory bladder masses detected with contrastenhanced ultrasound (CEUS): A relatively frequent but

Malignant Breast Masses Pak Armed Forces Med J 2014; 64 (1): 4-8 ORIGINAL ARTICLES. Sadaf Aziz, Arfan-ul-Haq*, Asad Maqbool Ahmad

Liver Cancer (Hepatocellular Carcinoma or HCC) Overview

Liver Tumors. Prof. Dr. Ahmed El - Samongy

간암의조직검사 : 언제, 어떻게? 계명대학교의과대학내과학교실 정우진

: TP6.3 g dl, Alb4.3 g dl, GOT17 IU l, GPT26 IU l,

Radiation burden of hepatocellular carcinoma screening program in hepatitis B virus patients should we recommend magnetic resonance imaging instead?

Hepatocelluar nodules in liver cirrhosis: hemodynamic evaluation (angiographyassisted CT) with special reference to multi-step hepatocarcinogenesis

Diffusion-weighted images (DWI) without ADC values in assessment of small focal nodules in cirrhotic liver

CONTRAST-ENHANCED ULTRASOUND: PRINCIPLES OF CLINICAL UTILISATION

Management. Chapter 11. Primary Author. Contributing Authors. University of Toronto & University of Ottawa. Illustrators & figure contributors

Complete Summary GUIDELINE TITLE. Liver lesion characterization. BIBLIOGRAPHIC SOURCE(S)

Contrast enhanced ultrasound (CEUS) in gallbladder and bile duct pathology: technique, interpretation and clinical applications

Simplifying liver assessment in internal medicine

Hepatic Imaging: What Every Practitioner Should Know

Recently role of non-invasive diagnostics methods

Differentiation Between Benign and Malignant Hepatic Lesions

Contrast-enhanced ultrasound (CEUS) of focal liver lesions. A useful, rapid and accessible tool.

Liver Perfusion Analysis New Frontiers in Dynamic Volume Imaging. Case Study Brochure Chang Gung Memorial Hospital.

ULTRASOUND IN CHRONIC LIVER DISEASE

Quality ID #406: Appropriate Follow-up Imaging for Incidental Thyroid Nodules in Patients National Quality Strategy Domain: Effective Clinical Care

Impact of reader's experience in contrast-enhanced ultrasonography (CEUS) management of patients with indeterminate liver lesions

Prospective comparison between real time contrast enhanced and conventional ultrasound guidance in percutaneous biopsies of liver tumors.

Available online at Journal of the Chinese Medical Association 74 (2011) 62e68. Original Article

Contrast-enhanced ultrasound for assessing focal liver lesions.

CEUS LI-RADS: algorithm, implementation, and key differences from CT/MRI

Transcription:

116 ( 3. 0 cm), 146 ( 3. 0 cm) 42 48 ; 48, 5 CT 38 (79. 2 %),, ;6 ;4 3 1. 5 cm, 1 2. 2 cm 27 (56. 0 %) ; 14 (29. 0 %) 2 4,17 1 2, 4, 42, 87. 5 %(42/ 48 ), ; CT, ; ; ; Early diagnosis of small hepatocellular carcinoma in patients with cirrhosis using contrast 2 enhanced ultrasound CH EN M in2hua, DA I Ying, YA N Kun, YA N G Wei, W U Wei, L I J i2you, Z HA N G X iao2peng, Y I N S han2shan. Department of Ult rasound, School of Oncology, Peking Universit y, Bei j ing 100036, China Abstract Objective To investigate the perfusion and contrast enhancement patterns of small hepatocellular carcinoma ( HCC) in cirrhotic livers for the role of contrast2enhanced ultrasonography ( CEUS) in diagnosing small HCC in size less than 3 cm with different histological types. Methods One hundred and forty2six patient s with focal liver lesions were referred to CEUS. Forty2eight small lesions in 42 patient s were diagnosed pathologically as HCC by surgery or needle biopsy. A diagnostic score of 1 to 5 was given to each lesion before and after contrast injection. Contrast2enhanced CT was performed in all the cases within 15 days of CEUS. Re sults Following contrast administration, 38 ( 79. 2 %) moderately to poorly differentiated HCC lesions presented with fast early arterial phase enhancement and then a quick wash2out in the parenchymal phase. Six well2differentiated HCC lesions had a contrast2enhancement pattern of fast2in and slow2out. Three of 4 clear cell carcinomas with the size of 1. 5 cm had an enhancement pattern of slow2in and slow2out. Another clear cell carcinomas of 2. 2 cm in size showed fast2in and fast2out pattern. Before CEUS, only 27 lesions ( 56. 0 %) were definitely or tentatively diagnosed as malignant lesions. After CEUS,the diagnostic scores of 14 HCC lesions (29. 0 %) were increased 224 point s,while 17 lesions increased 1 point s. Forty2two lesions were correctly diagnosed as malignant, while 2 lesions could not be diagnosed as benign or malignant and 4 lesions were diagnosed as malignant tentatively. The diagnostic accuracy of CEUS was 87. 5 % ( 42/ 48 lesions ). Conclusions The contrast enhancement patterns of small HCC with different histological types in CEUS were usef ul for early diagnosis of small malignancies. CEUS might be an alternative method to other imaging techniques, such as CT to diagnose small HCC in cirrhotic patient s. Key words Ultrasonography ;Contrast media ;Liver neoplasms ;Liver cirrhosis,, : ( ZD199909) :100036, [1,2 ] ; CT ( CT) MRI, 1 cm [1,3 ] [429 ], 转载

117, 2002 2004 146, ( 3 cm) 42 48, 38, 4 ; 35 81, (58. 4 12. 8) 0. 8 1. 0 cm 1,1. 1 1. 5 cm 8,1. 6 2. 0 cm 16,2. 1 3. 0 cm 23, (2. 34 0. 73) cm 16 (38. 1 %), 9 > 400 ng/ ml 42, CT, 2 10 2 20 Bracco SonoVue, (SF6 ), 2. 5 m, p H 4. 5 7. 5 5 ml, 2. 4 ml ( 5 mg/ ml, SF6 12 mg/ ) 2 3 s Technos DU6 DU8 Cn TI CA 431/ CA430 E, 2. 5 5. 0 M Hz :,, ;, Cn TI,,, MI < 0. 05, ;, ;, 10 min 2 6 8 min, 1 3 3 10 ; 2, CT MRI ; ;, CT,, [10 ], ( ), ; 1, 2, 3, 4, 5 ; 2,, 18 G SPSS 10. 0, F, 2 Fisher CT, 44 ; S7 S8 3 3 < 2 cm, 1, 2 95. 5 %(42/ 44 ) 1 2 1 48 (s, gx s ) - 38 14. 14 5. 26 22. 14 7. 49 60. 00 45. 92 6 14. 83 3. 06 25. 00 9. 36 263. 67 152. 75 3 4 25. 67 8. 96 # 30. 33 9. 50 134. 67 67. 99 :, 3 F = 11. 065, P = 0. 00 ; # F = 2. 90, P = 0. 048 2 38 2 48,, 6,, 3 1,,,,

118,, ( 1) 81. 3 %(39/ 48 ), 38,1 2. 2 cm 6, ( 2) 13 21 s,,4 103 291 s, 2 380 s 495 s, 4,3 1. 5 cm, 21 38 s, 60 193 s,, ( 3) ;48 27 (56. 0 %) ; 14 (29. 0 %) 2 4,17 1,48 3 3 48 ( ) 1 2 3 4 5 0 5 16 19 8 0 0 2 4 42 4,2, 42 ; 3 cm 87. 5 % (42/ 48 ) 2 2,, 2 ; 2, 3, CT 2, 0. 8 1. 2 cm 1,45,, 2,,CT,A :, 2 cm ( ) B :, ( ) C : 11 s ( ), 32 s ( ), 2,69, 10,,AFP (6. 3 ng/ ml) A : ( ) B :, ( ), 426 s, ( ) C:495 s ( ), 3,59, 15, A : 1. 3 cm ( ),, B :, 35 s ( ), 40 s C :60 s ( )

119,, 2 3 cm,,,,,, 1/ 5 [11 ], ; < 2 cm, Levovist SonoVue [4,12 ] SonoVue Cn TI,,,,,, 3, 80 %, [ 13 ], [5 ], [14 ], 3 2 35 38 s, 1 21 s, 3 4 5 s 2 cm 52. 1 %(25 ),,, 19,, ;25 21 (84. 0 %) ; 4 18 G CT [ 15 ],2 3, 0. 8 1. 2 cm,,,,, 2, ; ; ;,,,,,, 3. 0 cm, ; CT, 1 Quaia E,Degobbis F, Tona G,et al. Differential patterns of contrast enhancement in different focal liver lesions after injection of the microbubble US contrast agent SonoVue. Radiol Med,2004,107 : 1552165. 2 Suzuki Y,Fujimoto Y, Hosoki Y,et al. Clinical utility of sequential imaging of hepatocellular carcinoma by contrast2enhanced power

120 Doppler ultrasonography. Eur J Radiol,2003,48 :2142219. 3 de Ledinghen V,Laharie D,Lecesne R,et al. Detection of nodules in liver cirrhosis : spiral computed tomography or magnetic resonance imaging? A prospective study of 88 nodules in 34 patient s. Eur J Gastroenterol Hepatol,2002,14 :1592165. 4 Leen E, Angerson WJ, Yarmenitis S, et al. Multi2cent re clinical study evaluating the efficacy of SonoVue (BR1),a new ultrasound contrast agent in Doppler investigation of focal hepatic lesions. Eur J Radiol,2002,41 :2002206. 5,..,2004,13 :38242. 6,,,..,2004,20 :3262330. 7,,..,2000,15 :1702172. 8,,,..,2003,12 :1012104. 9,,,..,2003,12 :3512354. 10 Kim T,Murakami T, Takahashi S,et al. Optimal phases of dynamic CT for detecting hepatocellular carcinoma : evaluation of unenhanced and triple2phase images. Abdom Imag, 1999, 24 : 4732 480. 11,.. :,2002. 90294. 12 Yucel C, Ozdemir H, Gurel S, et al. Detection and differential diagnosis of hepatic masses using pulse inversion harmonic imaging during the liver2specific late phase of contrast enhancement with Levovist. J Clin Ultrasound,2002,30 :2032212. 13 Mat sui O, Kadoya M, Kameyama T, et al. Benign and malignant nodules in cirrhotic livers : distinction based on blood supply. Radiology,1991,178 :4932497. 14. -. :,1996. 28242. 15 Dalla2Palma L, Bertolotto M, Quaia E, et al. Detection of liver metastases with pulse inversion harmonic imaging : preliminary results. Eur Radiol,1999,9 ( Suppl 3) :S3822387. ( :2004209203) 1,30 1 1,, : ( + + ), ( + ) :,,, : 2. 5 cm 2. 5 cm,, ( 1) :,,RI 0. 38 :, : 3 cm 3 cm,,,,, :, 2, 2 % 4 % [1 ], 80 % 90 %,,,,,,, [2 ],,,, 1 :266003 1,.. :,2003. 2432245. 2..,2002,18 :1462147. ( :2004207205)